Virus Yield Improvement for Downstream Processing: Exbumin®, Excipient Recombinant Albumin

Introduction Biological manufacturers face many challenges in downstream processing unit operations of viral based therapeutics that impact the integrity, stability, and potency of their final drug product. Human Serum Albumin (HSA) has been shown to improve yield during common downstream purification unit operations such as tangential flow filtration, depth filtration, chromatography, sterile filtration, and final …